3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Wilms Tumor
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Interventions
Cyclophosphamide
56
fludarabine phosphate
30
Filgrastim
28
Peripheral Blood Stem Cell Transplantation
27
Radiotherapy
26
Cyclosporine
23
Busulfan
23
Etoposide
21
Mycophenolic Acid
20
Whole-Body Irradiation
19
Antilymphocyte Serum
19
Methotrexate
17
Methylprednisolone
15
Melphalan
14
Cytarabine
13
Vincristine
11
Tacrolimus
11
Thiotepa
10
Prednisone
10
Cord Blood Stem Cell Transplantation
10
Rituximab
9
Doxorubicin
9
Leucovorin
7
aldesleukin
6
Granulocyte Colony-Stimulating Factor
6
sargramostim
5
Psychiatric Rehabilitation
5
Carboplatin
5
Therapeutics
4
Daunorubicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Dendritic Cell Sarcoma, Interdigitating
×
Lithium
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts